1-9 of 9
Hans-Guido Wendel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom
Journal: Blood
Blood (2023) 142 (Supplement 1): 6099.
https://doi.org/10.1182/blood-2023-185338
Published: 2023
Journal Articles

The cat-and-mouse game of BTK inhibition

Ana Portelinha, Hans-Guido Wendel
Journal: Blood
Blood (2023) 141 (13): 1502–1503.
https://doi.org/10.1182/blood.2022018936
Published: 2023
Journal Articles

Crebbp Mutations Disrupt Dynamic Enhancer Acetylation in B-Cells, Enabling HDAC3 to Drive Lymphomagenesis

Hsia-Yuan Ying, PhD, Yanwen Jiang, PhD, Ana Ortega-Molina, PhD, Huimin Geng, PhD, Dylan McNally, B.S., Ling Wang, M.S., Ashley Doane, B.S., Xabier Agirre, PhD, Haiying Ju, MS, David Poloway, B.S., Matt Teater, M.S., Sara Parsa, PhD, Daisuke Ennishi, David W Scott, MBChB, PhD, Rita Shaknovich, MD PhD, Randy D. Gascoyne, Wayne Tam, MD PhD, Olivier Elemento, PhD, Hans-Guido Wendel, MD, Ari Melnick, MD
Journal: Blood
Blood (2016) 128 (22): 735.
https://doi.org/10.1182/blood.V128.22.735.735
Published: 2016
Journal Articles

The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia

Joni Van der Meulen, Viraj Sanghvi, Konstantinos Mavrakis, Kaat Durinck, Fang Fang, Filip Matthijssens, Pieter Rondou, Monica Rosen, Tim Pieters, Peter Vandenberghe, Eric Delabesse, Tim Lammens, Barbara De Moerloose, Björn Menten, Nadine Van Roy, Bruno Verhasselt, Bruce Poppe, Yves Benoit, Tom Taghon, Ari M. Melnick, Frank Speleman, Hans-Guido Wendel, Pieter Van Vlierberghe
Journal: Blood
Blood (2015) 125 (1): 13–21.
https://doi.org/10.1182/blood-2014-05-577270
Published: 2015
Includes: Supplemental data
Journal Articles

Next-Generation Sequencing Suggests Complex, Heterogeneous Pathogenesis In Peripheral T-Cell Lymphoma Unspecified

Jonathan H. Schatz, MD, Steven M. Horwitz, MD, Matthew A. Lunning, DO, Igor Dolgalev, Kety Huberman, Adriana Heguy, Agnes Viale, PhD, Nicholas D. Socci, Mono Pirun, Julie Teruya-Feldstein, MD, Hans-Guido Wendel, MD
Journal: Blood
Blood (2013) 122 (21): 843.
https://doi.org/10.1182/blood.V122.21.843.843
Published: 2013
Journal Articles

A Novel Combination Therapy Based On the Genetics of Follicular Lymphoma

Hans-Guido Wendel, MD
Journal: Blood
Blood (2012) 120 (21): 1330.
https://doi.org/10.1182/blood.V120.21.1330.1330
Published: 2012
Journal Articles

MicroRNAs Mediate Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive B-ALL by Down-Regulating Key Tumor Suppressors

Jonathan H. Schatz, MD, Konstantinos Mavrakis, PhD, Andrew L Wolfe, Hans-Guido Wendel, MD
Journal: Blood
Blood (2011) 118 (21): 2553.
https://doi.org/10.1182/blood.V118.21.2553.2553
Published: 2011
Journal Articles

Targeting Translation Bypasses Pim Kinase Activity, a Common and Adverse Prognostic Marker In Lymphoma

Jonathan H. Schatz, MD, Julie Teruya-Feldstein, MD, Man Jiang, Andrew D Zelenetz, MD, Hans-Guido Wendel, MD
Journal: Blood
Blood (2010) 116 (21): 119.
https://doi.org/10.1182/blood.V116.21.119.119
Published: 2010
Journal Articles

Oncogenic Pim Kinase Activity Provides Resistance to Mtor Inhibition in Vitro and In Vivo .

Jonathan H Schatz, MD, Hans-Guido Wendel, MD
Journal: Blood
Blood (2009) 114 (22): 3974.
https://doi.org/10.1182/blood.V114.22.3974.3974
Published: 2009